MicardisPlus 40mg12.5mg tablets

Country: United Kingdom

Bahasa: Inggeris

Sumber: MHRA (Medicines & Healthcare Products Regulatory Agency)

Bahan aktif:

Telmisartan; Hydrochlorothiazide

Boleh didapati daripada:

Boehringer Ingelheim Ltd

Kod ATC:

C09DA07

INN (Nama Antarabangsa):

Telmisartan; Hydrochlorothiazide

Dos:

40mg ; 12.5mg

Borang farmaseutikal:

Tablet

Laluan pentadbiran:

Oral

Kelas:

No Controlled Drug Status

Jenis preskripsi:

Valid as a prescribable product

Ringkasan produk:

BNF: 02050502; GTIN: 5012816030053

Risalah maklumat

PACKAGE LEAFLET: INFORMATION FOR THE USER
MICARDISPLUS
®
40 MG/12.5 MG
TABLETS
telmisartan/hydrochlorothiazide
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your
doctor or pharmacist.
- This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them,
even if their signs of illness are the same as
yours.
- If you get any side effects talk to your doctor or
pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1. What MicardisPlus is and what it is used for
2. What you need to know before you take
MicardisPlus
3. How to take MicardisPlus
4. Possible side effects
5. How to store MicardisPlus
6. Contents of the pack and other information
1. WHAT MICARDISPLUS IS AND WHAT IT IS USED FOR
MicardisPlus is a combination of two active
substances, telmisartan and hydrochlorothiazide
in one tablet. Both of these substances help to
control high blood pressure.
- Telmisartan belongs to a group of medicines
called angiotensin II receptor antagonists.
Angiotensin-II is a substance produced in your
body which causes your blood vessels to narrow
thus increasing your blood pressure. Telmisartan
blocks the effect of angiotensin II so that the
blood vessels relax, and your blood pressure is
lowered.
- Hydrochlorothiazide belongs to a group of
medicines called thiazide diuretics, which cause
your urine output to increase, leading to a
lowering of your blood pressure.
High blood pressure, if not treated, can damage
blood vessels in several organs, which could lead
sometimes to heart attack, heart or kidney failure,
stroke, or blindness. There are usually no
symptoms of high blood pressure before damage
occurs. Thus it is important to regularly measure
blood pressure to verify if it is within the normal
range.
MICARDISPLUS IS USED TO treat high blood pressure
(essential hyper

Ciri produk

OBJECT 1
MICARDISPLUS 40 MG/12.5 MG TABLETS
Summary of Product Characteristics Updated 30-May-2017 | Boehringer
Ingelheim Limited
1. Name of the medicinal product
MicardisPlus 40 mg/12.5 mg tablets
MicardisPlus 80 mg/12.5 mg tablets
2. Qualitative and quantitative composition
MicardisPlus 40 mg/12.5 mg tablets
Each tablet contains 40 mg telmisartan and 12.5 mg
hydrochlorothiazide.
MicardisPlus 80 mg/12.5 mg tablets
Each tablet contains 80 mg telmisartan and 12.5 mg
hydrochlorothiazide.
Excipients with known effect
Each 40 mg/12.5 mg tablet contains 112 mg of lactose monohydrate and
169 mg sorbitol (E420).
Each 80 mg/12.5 mg tablet contains 112 mg of lactose monohydrate and
338 mg sorbitol (E420).
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Tablet.
MicardisPlus 40 mg/12.5 mg tablets
Red and white oval shaped two layer tablet of 5.2 mm engraved with the
company logo and the code 'H4'.
MicardisPlus 80 mg/12.5 mg tablets
Red and white oval shaped two layer tablet of 6.2 mm engraved with the
company logo and the code 'H8'.
4. Clinical particulars
4.1 Therapeutic indications
Treatment of essential hypertension.
MicardisPlus fixed dose combination (40 mg telmisartan/12.5 mg
hydrochlorothiazide and 80 mg
telmisartan/12.5 mg hydrochlorothiazide) is indicated in adults whose
blood pressure is not adequately
controlled on telmisartan alone.
4.2 Posology and method of administration
Posology
MicardisPlus should be taken in patients whose blood pressure is not
adequately controlled by telmisartan
alone. Individual dose titration with each of the two components is
recommended before changing to the
fixed dose combination. When clinically appropriate, direct change
from monotherapy to the fixed
combination may be considered.
• MicardisPlus 40 mg/12.5 mg may be administered once daily in
patients whose blood pressure is not
adequately controlled by Micardis 40 mg
• MicardisPlus 80 mg/12.5 mg may be administered once daily in
patients whose blood pressure is not
adequately controlled by Micardis 8